First Indigenous Vaccine For Cervical Cancer
- Approved on: 12 July 2022,
- Approved by: The Drugs Controller General of India (DGCI)
- Prepared by: Serum Institute of India
- Name of vaccine: CERVAVAC
- Specialty: India’s first Quadrivalent Human Papillomavirus vaccine (QHPV) against cervical cancer.
- Cervical cancer is a type of cancer that occurs in the cells of the cervix, the lower part of the uterus that connects to the vagina.